Cleared Traditional

AortaSTAT Occlusion Device

K210602 · Renalpro Medical, Inc. · Cardiovascular
Jul 2021
Decision
130d
Days
Class 2
Risk

About This 510(k) Submission

K210602 is an FDA 510(k) clearance for the AortaSTAT Occlusion Device, a Catheter, Intravascular Occluding, Temporary (Class II — Special Controls, product code MJN), submitted by Renalpro Medical, Inc. (Santa Clara, US). The FDA issued a Cleared decision on July 9, 2021, 130 days after receiving the submission on March 1, 2021. This device falls under the Cardiovascular review panel. Regulated under 21 CFR 870.4450.

Submission Details

510(k) Number K210602 FDA.gov
FDA Decision Cleared SESE
Date Received March 01, 2021
Decision Date July 09, 2021
Days to Decision 130 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF

Device Classification

Product Code MJN — Catheter, Intravascular Occluding, Temporary
Device Class Class II — Special Controls
CFR Regulation 21 CFR 870.4450

Similar Devices — MJN Catheter, Intravascular Occluding, Temporary

All 89
pREBOA-PRO Catheter
K243795 · Prytime Medical Devices, Inc. · Sep 2025
Bridge Plus Occlusion Balloon (590-002)
K251358 · Philips Image Guided Therapy Devices · Jun 2025
preCARDIA Occlusion System
K221294 · Abiomed, Inc. · Jun 2023
LANDMARK REBOA Catheter
K214060 · Zien Medical Technologies, Inc. · Sep 2022
Fogarty Occlusion Catheter
K211610 · Edwards Lifesciences, LLC · Feb 2022
RenovoCath
K212324 · Renovorx, Inc. · Aug 2021